Transglycosylation products generated by Talaromyces amestolkiae GH3 β-glucosidases: effect of hydroxytyrosol, vanillin and its glucosides on breast cancer cells.


Journal

Microbial cell factories
ISSN: 1475-2859
Titre abrégé: Microb Cell Fact
Pays: England
ID NLM: 101139812

Informations de publication

Date de publication:
31 May 2019
Historique:
received: 03 12 2018
accepted: 22 05 2019
entrez: 2 6 2019
pubmed: 4 6 2019
medline: 1 10 2019
Statut: epublish

Résumé

Transglycosylation represents one of the most promising approaches for obtaining novel glycosides, and plant phenols and polyphenols are emerging as one of the best targets for creating new molecules with enhanced capacities. These compounds can be found in diet and exhibit a wide range of bioactivities, such as antioxidant, antihypertensive, antitumor, neuroprotective and anti-inflammatory, and the eco-friendly synthesis of glycosides from these molecules can be a suitable alternative for increasing their health benefits. Transglycosylation experiments were carried out using different GH3 β-glucosidases from the fungus Talaromyces amestolkiae. After a first screening with a wide variety of potential transglycosylation acceptors, mono-glucosylated derivatives of hydroxytyrosol, vanillin alcohol, 4-hydroxybenzyl alcohol, and hydroquinone were detected. The reaction products were analyzed by thin-layer chromatography, high-pressure liquid chromatography, and mass spectrometry. Hydroxytyrosol and vanillyl alcohol were selected as the best options for transglycosylation optimization, with a final conversion yield of 13.8 and 19% of hydroxytyrosol and vanillin glucosides, respectively. NMR analysis confirmed the structures of these compounds. The evaluation of the biological effect of these glucosides using models of breast cancer cells, showed an enhancement in the anti-proliferative capacity of the vanillin derivative, and an improved safety profile of both glucosides. GH3 β-glucosidases from T. amestolkiae expressed in P. pastoris were able to transglycosylate a wide variety of acceptors. Between them, phenolic molecules like hydroxytyrosol, vanillin alcohol, 4-hydroxybenzyl alcohol, and hydroquinone were the most suitable for its interesting biological properties. The glycosides of hydroxytyrosol and vanillin were tested, and they improved the biological activities of the original aglycons on breast cancer cells.

Sections du résumé

BACKGROUND BACKGROUND
Transglycosylation represents one of the most promising approaches for obtaining novel glycosides, and plant phenols and polyphenols are emerging as one of the best targets for creating new molecules with enhanced capacities. These compounds can be found in diet and exhibit a wide range of bioactivities, such as antioxidant, antihypertensive, antitumor, neuroprotective and anti-inflammatory, and the eco-friendly synthesis of glycosides from these molecules can be a suitable alternative for increasing their health benefits.
RESULTS RESULTS
Transglycosylation experiments were carried out using different GH3 β-glucosidases from the fungus Talaromyces amestolkiae. After a first screening with a wide variety of potential transglycosylation acceptors, mono-glucosylated derivatives of hydroxytyrosol, vanillin alcohol, 4-hydroxybenzyl alcohol, and hydroquinone were detected. The reaction products were analyzed by thin-layer chromatography, high-pressure liquid chromatography, and mass spectrometry. Hydroxytyrosol and vanillyl alcohol were selected as the best options for transglycosylation optimization, with a final conversion yield of 13.8 and 19% of hydroxytyrosol and vanillin glucosides, respectively. NMR analysis confirmed the structures of these compounds. The evaluation of the biological effect of these glucosides using models of breast cancer cells, showed an enhancement in the anti-proliferative capacity of the vanillin derivative, and an improved safety profile of both glucosides.
CONCLUSIONS CONCLUSIONS
GH3 β-glucosidases from T. amestolkiae expressed in P. pastoris were able to transglycosylate a wide variety of acceptors. Between them, phenolic molecules like hydroxytyrosol, vanillin alcohol, 4-hydroxybenzyl alcohol, and hydroquinone were the most suitable for its interesting biological properties. The glycosides of hydroxytyrosol and vanillin were tested, and they improved the biological activities of the original aglycons on breast cancer cells.

Identifiants

pubmed: 31151435
doi: 10.1186/s12934-019-1147-4
pii: 10.1186/s12934-019-1147-4
pmc: PMC6544938
doi:

Substances chimiques

Benzaldehydes 0
Benzyl Alcohols 0
Glycosides 0
Hydroquinones 0
3,4-dihydroxyphenylethanol 10597-60-1
4-hydroxybenzyl alcohol 1A3AH1FP1B
vanillin CHI530446X
Cellulases EC 3.2.1.-
Phenylethyl Alcohol ML9LGA7468
vanillyl alcohol X7EA1JUA6M
hydroquinone XV74C1N1AE

Types de publication

Journal Article

Langues

eng

Sous-ensembles de citation

IM

Pagination

97

Subventions

Organisme : MINECO
ID : RTC-2014-1777-3
Organisme : MINECO
ID : BIO2015-68387-R
Organisme : Comunidad de Madrid
ID : S2013/MAE-2907

Références

J Agric Food Chem. 2000 Jun;48(6):2122-6
pubmed: 10888509
Chem Biol. 2001 Jul;8(7):627-33
pubmed: 11451664
Chembiochem. 2000 Nov 17;1(4):214-46
pubmed: 11828414
Glycobiology. 2002 Apr;12(4):43R-56R
pubmed: 12042244
Adv Enzymol Relat Subj Biochem. 1956;17:189-232
pubmed: 13313310
Eur J Pharm Sci. 2005 May;25(1):57-65
pubmed: 15854801
Aliment Pharmacol Ther. 2006 Sep 1;24(5):701-14
pubmed: 16918875
J Pharm Pharmacol. 2007 Sep;59(9):1235-40
pubmed: 17883894
Dermatol Ther. 2007 Sep-Oct;20(5):308-13
pubmed: 18045355
Nucleic Acids Res. 2009 Jan;37(Database issue):D233-8
pubmed: 18838391
Mol Nutr Food Res. 2009 May;53(5):600-8
pubmed: 19194970
Cytotechnology. 2009 Jan;59(1):45-53
pubmed: 19353300
Mol Nutr Food Res. 2009 Jul;53(7):887-96
pubmed: 19536871
Chem Pharm Bull (Tokyo). 1990 Nov;38(11):3020-3
pubmed: 2085881
Food Chem Toxicol. 2011 Jan;49(1):179-84
pubmed: 20955751
Molecules. 2010 Oct 21;15(10):7313-52
pubmed: 20966876
Br J Pharmacol. 2011 Jun;163(4):835-44
pubmed: 21366552
Molecules. 2011 Jun 24;16(7):5349-61
pubmed: 21705974
Eur J Nutr. 2012 Jun;51(4):455-64
pubmed: 21805082
Appl Microbiol Biotechnol. 2013 Jan;97(1):159-69
pubmed: 22311644
Enzyme Microb Technol. 2012 Dec 10;51(6-7):311-8
pubmed: 23040385
Mol Nutr Food Res. 2013 Jan;57(1):71-83
pubmed: 23193056
J Agric Food Chem. 2013 Feb 6;61(5):1081-7
pubmed: 23330921
J Med Food. 2013 Sep;16(9):777
pubmed: 23905649
J Agric Food Chem. 2014 Feb 19;62(7):1449-55
pubmed: 24479643
Curr Opin Biotechnol. 2015 Apr;32:42-46
pubmed: 25448231
Mol Plant. 2015 Jan;8(1):40-57
pubmed: 25578271
Redox Biol. 2015 Aug;5:347-357
pubmed: 26122399
Appl Environ Microbiol. 2015 Sep;81(18):6380-92
pubmed: 26150469
ACS Chem Biol. 2016 Jul 15;11(7):1784-94
pubmed: 27176929
Appl Microbiol Biotechnol. 2016 Oct;100(20):8769-78
pubmed: 27229725
Microb Cell Fact. 2016 Oct 4;15(1):171
pubmed: 27716291
Oxid Med Cell Longev. 2016;2016:9734816
pubmed: 28077989
Biotechnol Biofuels. 2017 Jun 23;10:161
pubmed: 28649280
J Agric Food Chem. 2017 Dec 6;65(48):10526-10533
pubmed: 29119794
Biotechnol Biofuels. 2017 Nov 6;10:256
pubmed: 29142591
Biotechnol Biofuels. 2018 Apr 27;11:123
pubmed: 29719566
Molecules. 2018 May 25;23(6):null
pubmed: 29799509
Nutr Rev. 1998 Nov;56(11):317-33
pubmed: 9838798

Auteurs

Juan Antonio Méndez-Líter (JA)

Department of Microbial and Plant Biotechnology, Centro de Investigaciones Biológicas, CSIC, Ramiro de Maeztu 9, 28040, Madrid, Spain.

Isabel Tundidor (I)

Department of Biochemistry and Molecular Biology, Complutense University, Madrid, Spain.
Instituto de Investigación Hospital 12 de Octubre, Madrid, Spain.

Manuel Nieto-Domínguez (M)

Department of Microbial and Plant Biotechnology, Centro de Investigaciones Biológicas, CSIC, Ramiro de Maeztu 9, 28040, Madrid, Spain.

Beatriz Fernández de Toro (BF)

Department of Chemical and Physical Biology, Centro de Investigaciones Biológicas, CSIC, Ramiro de Maeztu 9, 28040, Madrid, Spain.

Andrés González Santana (A)

Glycochemistry and Molecular Recognition Group, Instituto de Química Orgánica General (IQOG-CSIC), Calle Juan de la Cierva, 3, 28006, Madrid, Spain.

Laura Isabel de Eugenio (LI)

Department of Microbial and Plant Biotechnology, Centro de Investigaciones Biológicas, CSIC, Ramiro de Maeztu 9, 28040, Madrid, Spain.

Alicia Prieto (A)

Department of Microbial and Plant Biotechnology, Centro de Investigaciones Biológicas, CSIC, Ramiro de Maeztu 9, 28040, Madrid, Spain.

Juan Luis Asensio (JL)

Glycochemistry and Molecular Recognition Group, Instituto de Química Orgánica General (IQOG-CSIC), Calle Juan de la Cierva, 3, 28006, Madrid, Spain.

Francisco Javier Cañada (FJ)

Department of Chemical and Physical Biology, Centro de Investigaciones Biológicas, CSIC, Ramiro de Maeztu 9, 28040, Madrid, Spain.

Cristina Sánchez (C)

Department of Biochemistry and Molecular Biology, Complutense University, Madrid, Spain.
Instituto de Investigación Hospital 12 de Octubre, Madrid, Spain.

María Jesús Martínez (MJ)

Department of Microbial and Plant Biotechnology, Centro de Investigaciones Biológicas, CSIC, Ramiro de Maeztu 9, 28040, Madrid, Spain. mjmartinez@cib.csic.es.

Articles similaires

[Redispensing of expensive oral anticancer medicines: a practical application].

Lisanne N van Merendonk, Kübra Akgöl, Bastiaan Nuijen
1.00
Humans Antineoplastic Agents Administration, Oral Drug Costs Counterfeit Drugs

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female
Humans United States Aged Cross-Sectional Studies Medicare Part C
1.00
Humans Yoga Low Back Pain Female Male

Classifications MeSH